• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成素释放激素类似物(布舍瑞林)对隐睾的长期影响。

Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.

作者信息

Hadziselimović F, Huff D, Duckett J, Herzog B, Elder J, Snyder H, Buser M

机构信息

University Children's Hospital, Basel, Switzerland.

出版信息

J Urol. 1987 Oct;138(4 Pt 2):1043-5. doi: 10.1016/s0022-5347(17)43495-1.

DOI:10.1016/s0022-5347(17)43495-1
PMID:2888905
Abstract

We studied 48 prepubertal boys with cryptorchidism between 1 year 3 months and 11 years old who were treated with buserelin every other day for 6 months. Urinary luteinizing and follicle-stimulating hormones, and testosterone remained unchanged during the entire treatment period. In boys older than 7 years a slight but significant increase in testosterone was noted in the first morning voided urine at the end of treatment. Testicular biopsies were obtained at orchiopexy in all patients in whom testicular descent was not complete (83 per cent). A significant increase in the number of germ cells was observed in patients with unilateral and those with bilateral cryptorchidism, indicating that 6 months of buserelin therapy improved the fertility status even when testes were in an undescended position during treatment.

摘要

我们研究了48名1岁3个月至11岁的青春期前隐睾男孩,他们每隔一天接受布舍瑞林治疗6个月。在整个治疗期间,尿促黄体生成素、促卵泡生成素和睾酮水平保持不变。在7岁以上的男孩中,治疗结束时首次晨尿中的睾酮有轻微但显著的升高。所有睾丸未完全下降的患者(83%)在睾丸固定术中均进行了睾丸活检。单侧和双侧隐睾患者的生殖细胞数量均显著增加,这表明即使在治疗期间睾丸处于未降位置,6个月的布舍瑞林治疗仍改善了生育状况。

相似文献

1
Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.促黄体生成素释放激素类似物(布舍瑞林)对隐睾的长期影响。
J Urol. 1987 Oct;138(4 Pt 2):1043-5. doi: 10.1016/s0022-5347(17)43495-1.
2
Treatment of cryptorchidism with low doses of buserelin over a 6-months period.为期6个月使用低剂量布舍瑞林治疗隐睾症。
Eur J Pediatr. 1987;146 Suppl 2:S56-8. doi: 10.1007/BF00452876.
3
Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue.用促黄体生成素释放激素类似物成功治疗有不育风险的单侧隐睾男孩。
Int Braz J Urol. 2008 May-Jun;34(3):319-26; discussion 327-8. doi: 10.1590/s1677-55382008000300009.
4
The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.用布舍瑞林治疗的隐睾症男孩附睾、鞘突和睾丸下降的行为
Eur J Pediatr. 1993;152 Suppl 2:S38-42. doi: 10.1007/BF02125436.
5
Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life.在成功进行睾丸固定术后使用促黄体生成素释放激素类似物治疗,可显著提高日后生育的几率。
J Urol. 1997 Sep;158(3 Pt 2):1193-5. doi: 10.1097/00005392-199709000-00130.
6
Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study.
J Urol. 1992 Aug;148(2 Pt 2):617-21. doi: 10.1016/s0022-5347(17)36670-3.
7
Undescended testis histology correlation with adult hormone levels and semen analysis.隐睾症组织学与成人激素水平和精液分析的相关性。
J Urol. 2012 Oct;188(4 Suppl):1429-35. doi: 10.1016/j.juro.2012.04.025. Epub 2012 Aug 17.
8
Screening for cryptorchid boys risking sterility and results of long-term buserelin treatment after successful orchiopexy.对有不育风险的隐睾症男孩进行筛查以及成功进行睾丸固定术后长期使用布舍瑞林治疗的结果。
Eur J Pediatr. 1987;146 Suppl 2:S59-62. doi: 10.1007/BF00452877.
9
Erythropoietin may reduce the risk of germ cell loss in boys with cryptorchidism.促红细胞生成素可能降低隐睾症男孩生殖细胞丢失的风险。
Horm Res. 2001;55(1):41-5. doi: 10.1159/000049963.
10
Bilateral undescended testes classified according to preoperative and postoperative status of gonadotropins and inhibin B in relation to testicular histopathology at bilateral orchiopexy in infant boys.双侧未降睾丸根据术前和术后促性腺激素和抑制素 B 与婴儿男孩双侧睾丸固定术时睾丸组织病理学的关系进行分类。
J Urol. 2012 Oct;188(4 Suppl):1436-42. doi: 10.1016/j.juro.2012.02.2551. Epub 2012 Aug 17.

引用本文的文献

1
Trends in the treatment of undescended testes: a pediatric tertiary care center experience from Croatia.隐睾治疗的趋势:克罗地亚一家儿科三级护理中心的经验
World J Pediatr Surg. 2022 Oct 31;5(4):e000461. doi: 10.1136/wjps-2022-000461. eCollection 2022.
2
Temperature is not a major factor in the differentiation of gonocytes into ad spermatogonia and fertility outcome in congenitally cryptorchid boys.在先天性隐睾男孩中,温度并非是生殖母细胞分化为A 型精原细胞及生育结局的主要影响因素。
Basic Clin Androl. 2022 Jan 10;32(1):2. doi: 10.1186/s12610-021-00152-6.
3
Undescended testis and infertility-Is hormonal therapy indicated?
隐睾与不育——激素治疗是否适用?
Transl Androl Urol. 2014 Dec;3(4):377-81. doi: 10.3978/j.issn.2223-4683.2014.11.10.
4
Undescended testicle: An update on fertility in cryptorchid men.隐睾:隐睾男性生育能力的最新进展
Indian J Med Res. 2015 Feb;141(2):163-71. doi: 10.4103/0971-5916.155544.
5
Epidemiology, classification and management of undescended testes: does medication have value in its treatment?隐睾的流行病学、分类及管理:药物治疗是否具有价值?
J Clin Res Pediatr Endocrinol. 2013;5(2):65-72. doi: 10.4274/Jcrpe.883.
6
Does treatment with human chorionic gonadotropin induce reversible changes in undescended testes in boys?人绒毛膜促性腺激素治疗是否会引起男孩隐睾的可逆性变化?
Pediatr Surg Int. 1997;12(8):591-4. doi: 10.1007/BF01371906.
7
The impalpable testis.无法触及的睾丸
Ann R Coll Surg Engl. 1995 Jan;77(1):3-6.
8
Treatment of cryptorchidism with low doses of buserelin over a 6-months period.为期6个月使用低剂量布舍瑞林治疗隐睾症。
Eur J Pediatr. 1987;146 Suppl 2:S56-8. doi: 10.1007/BF00452876.
9
Current concepts in inguinal hernia in infants and children.婴幼儿腹股沟疝的当前概念
World J Surg. 1989 Sep-Oct;13(5):506-15. doi: 10.1007/BF01658863.